Guanze Medical Information Industry (Holding) Co., Ltd. (2427) and FUNDE (HONG KONG) INVESTMENT HOLDINGS CO., LIMITED have released a clarification announcement regarding the terms outlined in a previous Rule 3.5 Announcement dated 11 February 2026. The revised paragraphs focus on public float measures, detailing steps the Hong Kong Stock Exchange may take should a “Significant Public Float Shortfall” occur at the close of the Offer or if a false or disorderly market arises. Potential measures include suspending trading, adding a designated marker to the stock name of Guanze Medical, and possibly canceling its listing if public float requirements under Rule 13.32B are not met within 18 months.

To address any shortfall in public float, an application may be made for a temporary waiver from Rule 8.08(1)(a), and the Offeror intends to restore public float by placing or selling a sufficient number of Shares to parties not acting in concert with the Offeror. The announcement confirms that the directors of both the Offeror and Guanze Medical will undertake to ensure that the Company remains in compliance with the Listing Rules if the public float falls below required thresholds, thereby aiming to maintain the Company’s listing status on the Stock Exchange. All other information in the Rule 3.5 Announcement remains unchanged.